Press-release for stocks for GLAXF

| -3.76% | O: -2.33% H: 3.68% C: 2.44%
NVSEF | News | $93.6375 6.88% 82K

| -7.38% | O: 0.89% H: 0.0% C: 0.0%
NVS | News | $93.08 -0.13% 0.13% 1.1M

| -7.81% | O: 1.03% H: 0.14% C: 0.05%
JNJ | News | $144.77 0.22% 0.22% 7.9M

| -10.29% | O: 0.28% H: 0.0% C: 0.0%
GSK | $39.6 -0.88% 0.03% 2.6M

| -5.49% | O: 0.26% H: 0.18% C: 0.05%
BMY | $47.84 -0.87% 0.48% 9.9M

| -4.91% | O: 0.37% H: 0.27% C: -0.1%
integration reach momentum infection treatment market

Dietary Supplement Market to Reach US$ 170.1 Billion by 2034 Amid Rising Focus on Preventive Healthcare and Weight Management
Published: 2024-01-16 (Crawled : 20:00) - prnewswire.com
GLAXF | $20.2 0.65% -14.18% 290

| 3.11% | O: -0.56% H: 0.0% C: 0.0%
NUS 4 | $12.36 0.65% 0.0% 340K

Consumer Non-Durables

| -30.01% | O: -2.04% H: 1.85% C: -0.12%
GSK | $39.6 -0.88% 0.03% 2.6M

| -0.7% | O: -0.08% H: 0.1% C: -0.18%
ABT | News | $105.9 -3.03% 0.38% 11M

| -4.89% | O: 0.12% H: 0.77% C: 0.27%
management reach market

Gonorrhea Therapeutics Market to grow by USD 506.68 million from 2022 to 2027; North America accounts for 39% of market growth - Technavio
Published: 2023-11-21 (Crawled : 20:00) - prnewswire.com
GLAXF | $20.2 0.65% -14.18% 290

| 12.47% | O: -3.23% H: 0.0% C: -0.35%
GSK | $39.6 -0.88% 0.03% 2.6M

| 11.93% | O: -0.23% H: 0.2% C: -0.28%
america therapeutics growth market

Global Best Selling Pharmaceutical Drugs Analysis Report 2023: Revenue Forecast of the Top 50 Pharmaceutical Drugs and Assessment of their Regulatory Landscape through 2021
Published: 2023-03-10 (Crawled : 20:00) - prnewswire.com
AMGN | $264.07 -0.59% -0.59% 1.6M

| Email alert Add to watchlist
CSLLY | $87.96 0.15% 3.3% 45K

| Email alert Add to watchlist
MNK | $0.3402 -0.06% 540K

| Email alert Add to watchlist
SNY | News | $46.11 0.68% 0.7% 3.5M

| Email alert Add to watchlist
GLAXF | $20.2 0.65% -14.18% 290

| Email alert Add to watchlist
MNKPF | $17.25

| Email alert Add to watchlist
ABBV | $164.25 1.05% 0.26% 3M

| Email alert Add to watchlist
ENDP | $0.2926 -9.6%

| Email alert Add to watchlist
ALPMY | News | $9.46 1.29% -1.11% 500K

| Email alert Add to watchlist
VTRS | $11.1 -0.18% -0.23% 4.7M

| Email alert Add to watchlist
NVSEF | News | $93.6375 6.88% 82K

| Email alert Add to watchlist
UCBJY | $64.07 1.2% -4.38% 72K

| Email alert Add to watchlist
NVS | News | $93.08 -0.13% 0.13% 1.1M

| Email alert Add to watchlist
ALPMF | News | $9.594 1.2% 43.47% 0

| Email alert Add to watchlist
SNYNF | News | $92.7 0.63% -2.18% 1.4K

| Email alert Add to watchlist
BHC | $8.66 -0.92% -0.58% 2.2M

| Email alert Add to watchlist
UCBJF | $126.05 2.48% -39.66% 0

| Email alert Add to watchlist
TEVJF | $12.37 -24.22% 380

| Email alert Add to watchlist
ENDPQ | $0.0006 -85.0% -50.0% 220K

| Email alert Add to watchlist
CMXHF | $172.54 -1.41% -19.21% 50

| Email alert Add to watchlist
JNJ | News | $144.77 0.22% 0.22% 7.9M

| Email alert Add to watchlist
MNKKQ | $0.02

| Email alert Add to watchlist
GSK | $39.6 -0.88% 0.03% 2.6M

| Email alert Add to watchlist
NVO | News | $124.53 0.88% 0.19% 2.5M

| Email alert Add to watchlist
global report

Global API and Pharmaceutical Excipients Market Report 2022-2029 Featuring Catalent, Divis Labs, Euroapi Lonza, Pfizer, Samsung Biologics, Teva, Thermo Fisher Scientific, Wuxi Apptec, & Wuxi Biologics
Published: 2023-03-06 (Crawled : 20:00) - prnewswire.com
CMXHF | $172.54 -1.41% -19.21% 50

| -10.86% | O: -0.86% H: 0.33% C: 0.33%
CSLLY | $87.96 0.15% 3.3% 45K

| -11.33% | O: -0.02% H: 0.54% C: -1.7%
AZNCF | $140.15 3.58% -4.19% 560

| 3.92% | O: -2.57% H: 1.62% C: 1.62%
TMO | News | $547.25 -1.32% -1.51% 1.2M

| -2.02% | O: 0.41% H: 0.39% C: -2.14%
TEVA | $13.18 0.69% -0.3% 6.2M

| 33.0% | O: -1.21% H: 0.43% C: -3.58%
TAK | $13.15 -0.61% 0.0% 1.5M

| -15.92% | O: 0.83% H: 0.06% C: -1.2%
PRGO | $30.04 0.27% 0.97% 650K

| -18.72% | O: 0.76% H: 1.91% C: 1.26%
GSK | $39.6 -0.88% 0.03% 2.6M

| 14.95% | O: 0.32% H: 0.17% C: -1.53%
LLY | News | $750.77 0.54% 0.22% 2.8M

| 135.38% | O: 0.01% H: 0.42% C: -2.62%
CTLT | $55.96 0.32% 0.0% 1.9M

| -21.81% | O: 0.11% H: 0.53% C: -5.05%
BMY | $47.84 -0.87% 0.48% 9.9M

| -29.96% | O: 0.41% H: 0.04% C: -1.71%
ALB | News | $114.39 0.25% 0.79% 1.8M

Process Industries

| -55.0% | O: -0.95% H: 1.02% C: -2.19%
ABBV | $164.25 1.05% 0.26% 3M

| 5.57% | O: 0.19% H: 0.06% C: -1.7%
SNY | News | $46.11 0.68% 0.7% 3.5M

| -3.39% | O: 0.65% H: 0.0% C: 0.0%
GILD | $66.93 -0.57% -0.55% 3.8M

| -17.48% | O: 0.23% H: 0.0% C: -1.25%
BIIB | $192.16 -1.53% -1.57% 1.1M

| -27.79% | O: 0.28% H: 0.0% C: -2.26%
AZN | $68.53 0.39% 0.39% 3.2M

| 5.74% | O: 0.9% H: 0.28% C: -1.3%
global report market

Osteoarthritis therapeutics market to grow at a CAGR of 8.97% from 2022 to 2027: Growth opportunities led by Abbott Laboratories and Alvogen Iceland ehf among others- Technavio
Published: 2023-03-06 (Crawled : 20:00) - prnewswire.com
NVSEF | News | $93.6375 6.88% 82K

| 32.19% | O: -2.12% H: 0.0% C: -1.26%
VTRS | $11.1 -0.18% -0.23% 4.7M

| 2.21% | O: 0.09% H: 0.18% C: -1.29%
NVS | News | $93.08 -0.13% 0.13% 1.1M

| 9.61% | O: 0.11% H: 0.05% C: -1.21%
GSK | $39.6 -0.88% 0.03% 2.6M

| 14.95% | O: 0.32% H: 0.17% C: -1.53%
ABT | News | $105.9 -3.03% 0.38% 11M

| 5.04% | O: 0.11% H: 0.23% C: -2.8%
SNY | News | $46.11 0.68% 0.7% 3.5M

| -3.39% | O: 0.65% H: 0.0% C: 0.0%
ANIK | $25.69 0.71% 0.7% 53K

| -11.64% | O: -4.29% H: 1.19% C: -6.23%
osteoarthritis therapeutics growth market

Global Global Antimalarial Drugs Market Research Report 2022-2028 Featuring Cipla, GSK, Ipca, Merck, Novartis, Zydus Cadila, Sun Pharma, Strides Pharma, Glenmark Pharma, Lincoln Pharma
Published: 2023-02-17 (Crawled : 20:00) - prnewswire.com
GSK | $39.6 -0.88% 0.03% 2.6M

| Email alert Add to watchlist
GLAXF | $20.2 0.65% -14.18% 290

| Email alert Add to watchlist
NVSEF | News | $93.6375 6.88% 82K

| Email alert Add to watchlist
NVS | News | $93.08 -0.13% 0.13% 1.1M

| Email alert Add to watchlist
pharma research global report market

Pleurodynia Treatment Market Size to USD 24.61 Mn, Growing Prevalence of Viral Infections to Boost Market Growth - Technavio
Published: 2022-11-08 (Crawled : 20:00) - prnewswire.com
RBGPF | $52.0 2.32% 6.46% 34K

Consumer Non-Durables

| -19.17% | O: -1.91% H: 4.89% C: 0.2%
GLAXF | $20.2 0.65% -14.18% 290

| 29.99% | O: 3.44% H: 0.0% C: -3.27%
RBGLY | $10.29 -0.48% -2.05% 1.4M

| -21.33% | O: -1.61% H: 1.0% C: -0.16%
NVS | News | $93.08 -0.13% 0.13% 1.1M

| 13.75% | O: 0.84% H: 1.22% C: 0.55%
GSK | $39.6 -0.88% 0.03% 2.6M

| 22.91% | O: 0.06% H: 1.27% C: 0.56%
ABT | News | $105.9 -3.03% 0.38% 11M

| 8.32% | O: 0.27% H: 1.36% C: -0.45%
SNY | News | $46.11 0.68% 0.7% 3.5M

| 6.91% | O: 0.72% H: 0.69% C: -0.23%
treatment growing infections growth market

Pharmaceutical Drug Delivery Global Market Report 2022: Adoption of Nano-Based Drug Delivery Systems Presents Opportunities
Published: 2022-10-11 (Crawled : 20:00) - prnewswire.com
GLAXF | $20.2 0.65% -14.18% 290

| 32.29% | O: -1.93% H: 0.0% C: -0.17%
AZNCF | $140.15 3.58% -4.19% 560

| 23.95% | O: -0.15% H: 0.61% C: 0.09%
NVS | News | $93.08 -0.13% 0.13% 1.1M

| 22.7% | O: -0.07% H: 0.48% C: -0.66%
JNJ | News | $144.77 0.22% 0.22% 7.9M

| -9.82% | O: 1.29% H: 0.0% C: 0.0%
GSK | $39.6 -0.88% 0.03% 2.6M

| 30.13% | O: 0.0% H: 0.67% C: -0.2%
LLY | News | $750.77 0.54% 0.22% 2.8M

| 129.17% | O: -0.07% H: 1.92% C: -0.86%
BSX | $67.96 -0.24% -0.49% 5.2M

| 72.19% | O: 0.38% H: 0.35% C: -0.28%
ABBV | $164.25 1.05% 0.26% 3M

| 15.84% | O: 0.09% H: 1.0% C: -1.17%
MMM | $90.96 -0.1% 0.39% 2.9M

Producer Manufacturing

| -16.43% | O: -0.25% H: 1.04% C: 0.35%
SNY | News | $46.11 0.68% 0.7% 3.5M

| 17.42% | O: 0.76% H: 0.0% C: 0.0%
AZN | $68.53 0.39% 0.39% 3.2M

| 23.44% | O: -0.67% H: 0.95% C: 0.25%
AMGN | $264.07 -0.59% -0.59% 1.6M

| 8.76% | O: -0.44% H: 1.79% C: 0.85%
drug global report market

Respiratory Drugs Market size to grow by USD 26.95 Bn at 5.96% CAGR during 2026, Discover Company Insights in Technavio
Published: 2022-09-19 (Crawled : 20:00) - prnewswire.com
GLAXF | $20.2 0.65% -14.18% 290

| 30.32% | O: -6.97% H: 7.7% C: -0.76%
AZNCF | $140.15 3.58% -4.19% 560

| 21.94% | O: -0.34% H: 6.64% C: -0.06%
NVSEF | News | $93.6375 6.88% 82K

| 47.56% | O: 1.96% H: 0.0% C: 0.0%
NVS | News | $93.08 -0.13% 0.13% 1.1M

| 15.3% | O: -0.82% H: 0.07% C: -0.61%
GSK | $39.6 -0.88% 0.03% 2.6M

| 28.65% | O: -0.71% H: 0.2% C: -0.23%
ABBV | $164.25 1.05% 0.26% 3M

| 14.91% | O: -0.59% H: 0.47% C: -0.04%
ABT | News | $105.9 -3.03% 0.38% 11M

| 3.69% | O: -1.25% H: 0.23% C: -0.47%
AZN | $68.53 0.39% 0.39% 3.2M

| 17.72% | O: -1.16% H: 0.56% C: 0.14%
respiratory market

Insights on the Biologics Global Market to 2027 - by Source, Product, Disease, Manufacturing and Region
Published: 2022-07-19 (Crawled : 20:00) - prnewswire.com
GLAXF | $20.2 0.65% -14.18% 290

| 21.25% | O: 36.07% H: 0.0% C: -9.7%
AZNCF | $140.15 3.58% -4.19% 560

| 0.56% | O: -3.45% H: 0.0% C: 0.0%
NVSEF | News | $93.6375 6.88% 82K

| 31.04% | O: -4.54% H: 3.88% C: 3.88%
NVS | News | $93.08 -0.13% 0.13% 1.1M

| 8.23% | O: -0.81% H: 0.05% C: -1.27%
JNJ | News | $144.77 0.22% 0.22% 7.9M

| -17.8% | O: -2.23% H: 0.0% C: 0.0%
GSK | $39.6 -0.88% 0.03% 2.6M

| -9.82% | O: -0.48% H: 0.0% C: -4.81%
ABBV | $164.25 1.05% 0.26% 3M

| 9.38% | O: -0.14% H: 0.0% C: 0.0%
SNY | News | $46.11 0.68% 0.7% 3.5M

| -9.96% | O: -0.62% H: 0.0% C: 0.0%
AZN | $68.53 0.39% 0.39% 3.2M

| 0.15% | O: -1.88% H: 0.15% C: -1.63%
AMGN | $264.07 -0.59% -0.59% 1.6M

| 7.93% | O: -0.25% H: 0.71% C: -0.03%
global market

Global Smart Inhalers Market to 2027 - Size, Share & Industry Trends Analysis Report
Published: 2022-05-23 (Crawled : 20:00) - prnewswire.com
GLAXF | $20.2 0.65% -14.18% 290

| -29.28% | O: -2.41% H: 0.0% C: -1.7%
AZNCF | $140.15 3.58% -4.19% 560

| 3.22% | O: -0.21% H: 2.54% C: 1.27%
NVSEF | News | $93.6375 6.88% 82K

| 24.64% | O: 0.17% H: 0.0% C: 0.0%
NVS | News | $93.08 -0.13% 0.13% 1.1M

| 3.35% | O: 1.17% H: 0.0% C: 0.0%
GSK | $39.6 -0.88% 0.03% 2.6M

| -11.73% | O: -0.13% H: 0.0% C: 0.0%
OPK | $1.25 3.31% 3.59% 3.5M

| -59.68% | O: -1.94% H: 2.14% C: -0.33%
AZN | $68.53 0.39% 0.39% 3.2M

| 2.79% | O: 0.51% H: 0.0% C: 0.0%
report smart market

Global Schizophrenia Drugs Market Research Report 2022-2027 - Increasing Admission to The Internet Facilities Globally Boosts the Market for Online Pharmacies
Published: 2022-04-26 (Crawled : 20:00) - prnewswire.com
GLAXF | $20.2 0.65% -14.18% 290

| -25.67% | O: 3.86% H: 0.18% C: 0.18%
JNJ | News | $144.77 0.22% 0.22% 7.9M

| -22.28% | O: -0.77% H: 0.0% C: 0.0%
GSK | $39.6 -0.88% 0.03% 2.6M

| -10.79% | O: 1.73% H: 1.53% C: 0.62%
LLY | News | $750.77 0.54% 0.22% 2.8M

| 165.45% | O: 0.21% H: 0.0% C: 0.0%
ABBV | $164.25 1.05% 0.26% 3M

| 4.99% | O: 0.03% H: 0.0% C: 0.0%
VNDA | News | $5.24 29.38% 22.56% 24M

| -48.68% | O: 0.2% H: 1.56% C: -1.17%
ALKS | News | $24.01 1.01% 1.16% 1.8M

| -11.13% | O: 13.01% H: 2.29% C: -0.95%
internet research report schizophrenia market

BiondVax Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
Published: 2022-03-28 (Crawled : 20:00) - biospace.com/
GLAXF | $20.2 0.65% -14.18% 290

| -2.88% | O: 3.37% H: 0.0% C: -0.19%
GSK | $39.6 -0.88% 0.03% 2.6M

| -8.25% | O: 0.58% H: 0.0% C: 0.0%
results

Global Dry Eye Syndrome Market (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts
Published: 2022-03-04 (Crawled : 20:00) - prnewswire.com
NVSEF | News | $93.6375 6.88% 82K

| Email alert Add to watchlist
GLAXF | $20.2 0.65% -14.18% 290

| Email alert Add to watchlist
NVS | News | $93.08 -0.13% 0.13% 1.1M

| Email alert Add to watchlist
GSK | $39.6 -0.88% 0.03% 2.6M

| Email alert Add to watchlist
dry eye eye growth syndros

Pain Management Therapeutics Market Worth US$ 97,041.9 Mn by end of 2028, Says Coherent Market Insights
Published: 2021-11-25 (Crawled : 20:00) - prnewswire.com
GLAXF | $20.2 0.65% -14.18% 290

| 0.25% | O: -0.1% H: 0.0% C: 0.0%
STMH | $0.1 -88.3% 0

| -41.45% | O: -1.23% H: 0.0% C: -5.1%
MCK | $525.92 -0.46% 0.0% 540K

Distribution Services

| 132.69% | O: -1.48% H: 0.0% C: 0.0%
JNJ | News | $144.77 0.22% 0.22% 7.9M

| -9.67% | O: 0.22% H: 0.0% C: 0.0%
GSK | $39.6 -0.88% 0.03% 2.6M

| -4.81% | O: -0.89% H: 0.22% C: -0.51%
LLY | News | $750.77 0.54% 0.22% 2.8M

| 186.55% | O: -0.08% H: 1.56% C: -0.55%
ABT | News | $105.9 -3.03% 0.38% 11M

| -12.98% | O: 3.05% H: 1.52% C: -1.51%
DRRX | $0.878 12.35% 11.0% 140K

| -26.96% | O: -1.87% H: 0.95% C: -2.86%
therapeutics market

BiondVax Announces Notice of Annual General Meeting of Shareholders and Provides a Business Update
Published: 2021-11-24 (Crawled : 20:00) - biospace.com/
GLAXF | $20.2 0.65% -14.18% 290

| -1.56% | O: -1.8% H: 0.0% C: 0.0%
SNYNF | News | $92.7 0.63% -2.18% 1.4K

| -7.3% | O: -1.33% H: 0.0% C: 0.0%
GSK | $39.6 -0.88% 0.03% 2.6M

| -4.16% | O: 0.85% H: 0.07% C: -0.17%
SNY | News | $46.11 0.68% 0.7% 3.5M

| -7.19% | O: -1.55% H: 0.0% C: 0.0%

Gainers vs Losers

57%

43%

Top 10 Gainers

INVO | $1.82 139.47% 56.82% 220M

WISA 4 | $9.25 51.64% 34.27% 64M

Electronic Technology

EDBL | News | $6.66 46.37% 32.39% 13M

GCTK | $0.715 36.27% 26.62% 600K

TIRX | $0.4848 7.49% 24.58% 5.9M

SRFM 4 | $0.3859 -12.3% 23.84% 660K

CTM | $0.2201 -2.31% 22.67% 48K

VNDA | News | $5.24 29.38% 22.56% 24M